http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015528804-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09 |
| filingDate | 2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015528804-A |
| titleOfInvention | Methods for inhibiting BNIP3 and preventing and treating ischemia-reperfusion injury with tetra-O-methylnordihydroguaiaretic acid |
| abstract | Here, for the prevention and treatment of ischemia-reperfusion (IR) injury in a subject's cardiomyocytes, the compound of formula I, or a solvate, or stereoisomer thereof is administered prior to, during, and Provided by applying to the subject in an amount sufficient to reduce or prevent IR injury to the heart tissue, either / and thereafter. Also provided are pharmaceutical compositions comprising a compound of formula I, or a solvate or stereoisomer thereof, and / or at least one additional therapeutic agent. |
| priorityDate | 2012-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.